期刊文献+

鲍曼不动杆菌的耐药性检测及多重耐药菌株质粒图谱分析 被引量:5

Study on resistance and plasmid profiles of Acinetobacter baumannii
暂未订购
导出
摘要 目的 对我院分离的鲍曼不动杆菌多重耐药菌株进行质粒图谱分析 ,以了解耐药菌的流行情况 ,指导临床合理用药。方法 收集用K B法对临床分离的鲍曼不动杆菌进行药敏试验 ,对多重耐药菌株进行质粒图谱分析。结果  14 3株鲍曼不动杆菌对临床常用抗生素均有不同程度的耐药 ,对第三代头孢菌素的耐药率最高 ,达 4 4 .1%~ 10 0 % ,其次为美洛培南和亚胺培南 ,分别为 2 1.7%和 2 3.3% ,对头孢哌酮 /舒巴坦的耐药率最低 ,为 9.5 %。质粒图谱显示被测 15株高度多重耐药菌株中有 7株质粒图谱相同 ,结合临床资料 ,定为流行株。结论 我院鲍曼不动杆菌呈现严重多重高度耐药现象 ,外科重症监护 (ICU) Objective To detect resistance of Acinetobacter baumannii and investigate epidemic state of multiple resistance strains by plasmid profiles analysis.Methods Collected Acinetobacter baumannii isolated from April 2000 to March 2002 and had antibiotics susceptibility tests as well as plasmid profiles analysis.Result Antibiotics susceptibility tests showed 143 strains were resistant to common clinical antibiotics in different degree.Most strains were resistant to the third generation Cephalosporins(between 44.1%~100%),to Meropenem and Imienem were 21.7% and 23.3% respectively.and resistance rate to Cefoperazon/Sulbactams was the lowest(9.5%) Plasmid profiles suggested that seven of fifteen severely multiple resistance strains had the same patterns.Conclusion Acinetobacter baumannii stains in our hospital represented serious multiple resistance. Intensive Care Unit of surgery ward had its own epidemic strains.
出处 《临床检验杂志》 CAS CSCD 北大核心 2003年第u04期57-59,共3页 Chinese Journal of Clinical Laboratory Science
关键词 鲍曼不动杆菌 耐药性 检测 多重耐药菌株 质粒图谱分析 Acinetobacter baumannii antibiotics susceptibility tests plasmaid profiles
  • 相关文献

参考文献11

二级参考文献28

  • 1李家泰,王彤,贾延军,李曼宁.临床分离耐药菌中超广谱β-内酰胺酶特性研究[J].中国临床药理学杂志,1996,12(2):81-84. 被引量:15
  • 2Mcmanus MC. Mechanism of bacterial resistance to antimicrobial agent[J]. AM J Health Syst Pharm, 1997,54 (12) :1420-1433.
  • 3Cappelletty D. Microbiology of bacterial respiratory infections[J]. Pediatr Infect Dis J, 1998,17 (8 Suppl): S55-61.
  • 4Hancock RE. Resistance mechanisms in Pseudomonas aeruginosa and other nonfermentative gram-negative bacteria[J]. Clin Infect Dis,1998,27(Suppl 1) :S93-99.
  • 5Szabo D, Barcs I, Rozgonyi F. Extended-spectrum betalactamases:an actual problem of hospital microbiology[J].Acta Microbiol Immunol Hung, 1997,44 (4): 309-325.
  • 6Rotschafer JC, Ostergaard BE. Combination Beta-lactam and beta-lactamase-inhibitor products: antimicrobial activity and efficiency of enzyme inhibition [J]. Am J Health Syst Pharm, 1995, 52 (6 Suppl 2):S15-22.
  • 7Du-Bios Sk, Marriott MS, Amyes SG. TEM-and SHV-derived extendedspectrum beta-lactamases: relationship between selection, structure and func tion [J]. J Antimicrob chemother,1995,35(1) :7-22.
  • 8Philippon A, Dusart J, Joris B, et al.The div ersity, structure and regula tion of beta-lactamases [J]. Cell Mol Life Science, 1998,54(4) :341-346.
  • 9Culebras E, Martez JL. Aminoglycoside resistance mediated by the bifunctional enzyme 6 ′-N-aminoglycoside acetyltransferase-2"-O-aminoglycoside phosphotransferase[J]. Front Biosci,1999,4:D1-8.
  • 10Brakstad OG, Maeland JA. Mechanisms of methicillin resistance in staphylococci[J]. APMIS, 1997, 105(4) :264 276.

共引文献240

同被引文献63

引证文献5

二级引证文献48

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部